by RIVANNA | Jul 15, 2025 | Press Releases
CHARLOTTESVILLE, VA – JULY 15, 2025 – RIVANNA®, developer of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) regarding the Accuro® 3S diagnostic ultrasound system and...
![Building a Health System to Support Aging Populations [6 Steps]](https://rivannamedical.com/wp-content/uploads/2025/06/Building-a-Health-System-to-Support-Aging-Populations-6-Steps.jpg)
by RIVANNA | Jun 29, 2025 | News
There is a significant shift occurring in the demographic composition of many developed countries: the aging of their populations. For the healthcare sector in the U.S., this presents a major challenge as a larger number of elderly people will need medical care....
by RIVANNA | Jun 10, 2025 | News
The management of labor pain has always walked a fine line between efficacy and impact on mobility. Traditional epidural techniques, while effective in pain relief, often result in significant motor block that limits maternal movement. This issue is increasingly at...
by RIVANNA | Jun 9, 2025 | Press Releases
— One of 65 startups chosen from nearly 1,500 global applicants — — Selected to participate in the world’s leading medtech accelerator — Charlottesville, VA, USA — June 9, 2025 — RIVANNA®, a medical device innovator and manufacturer focused on imaging-based medical...
by RIVANNA | Jun 5, 2025 | News, Video
In spinal anesthesia, precision isn’t optional — it’s foundational. Yet even with the increasing use of neuraxial ultrasound, traditional single-array probes still face key limitations: obstructed views, ambiguous needle trajectories, and inconsistent interpretation....
